Cargando…
Proteinuria and Renal Dysfunction after Intravitreal Injection of Bevacizumab in Patients with Diabetic Nephropathy: A Prospective Observational Study
BACKGROUND: Proliferative diabetic retinopathy (PDR) is one of the most important microvascular complications among the patients with diabetes. Intravitreal anti-vascular endothelial growth factor (anti-VEGF) agent enacts a key role in PDR. Some studies have dealt with the systemic exposure to these...
Autores principales: | Bagheri, Sina, Dormanesh, Banafshe, Afarid, Mehrdad, Sagheb, Mohammad Mahdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Salvia Medical Sciences Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344120/ https://www.ncbi.nlm.nih.gov/pubmed/34466447 http://dx.doi.org/10.22086/gmj.v0i0.1299 |
Ejemplares similares
-
Intravitreal Injection of Bevacizumab: Review of our previous Experience
por: Afarid, Mehrdad, et al.
Publicado: (2018) -
Intravitreal bevacizumab-induced exacerbation of proteinuria in diabetic nephropathy, and amelioration by switching to ranibizumab
por: Hanna, Ramy M, et al.
Publicado: (2020) -
Effect of a Single Intravitreal Bevacizumab Injection on Proteinuria in Patients With Diabetes
por: Chung, Yoo-Ri, et al.
Publicado: (2020) -
Comparison of Hemoglobin Levels Before and After Hemodialysis and Their Effects on Erythropoietin Dosing and Cost
por: Sagheb, Mohammad Mahdi, et al.
Publicado: (2016) -
Erectile Dysfunction Following Intravitreal Bevacizumab
por: Yohendran, Jayshan, et al.
Publicado: (2010)